1. A phase Ib trial with MK-8628/OTX015, a small molecule inhibitor of bromodomain (BRD) and extra-terminal (BET) proteins, in patients with selected advanced solid tumors. (December 2016) Authors: Massard, C.; Soria, J.C.; Stathis, A.; Delord, J.P.; Awada, A.; Peters, S.; Lewin, J.; Bekradda, M.; Rezai, K.; Zeng, Z.; Azher, H.; Perez, S.; Siu, L. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Outcomes of Common HPB Cases in Rural Australia: Identifying Predictors of Tertiary Care Management. (2021) Authors: Onasanya, O.; Azher, H.; Rouse, M.; Usatoff, V. Journal: HPB Issue: Volume 23(2021)Supplement 1 Page Start: S363 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗